Vycor Medical (VYCO) Income towards Parent Company (2010 - 2026)
Vycor Medical (VYCO) reported Income towards Parent Company of $13.0 for Q1 2026, up 126.53% year-over-year from $5.74 in Q1 2025, and up 104.23% on a QoQ basis from -$307.0 in Q4 2025.
Vycor Medical (VYCO) has 17 years of Income towards Parent Company data on file, last reported at $13.0 in Q1 2026.
- Quarterly Income towards Parent Company rose 126.53% year-over-year to $13.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2174.0 (down 1003.55% YoY) and the FY2025 annual result came in at -$2236.0, down 797.99% from the prior year.
- Income towards Parent Company climbed to $13.0 in Q1 2026 per VYCO's latest filing, from -$307.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $13.0 in Q1 2026 and bottomed at -$3094.0 in Q4 2023.
- The 5-year median for Income towards Parent Company is -$425.0 (2023), against an average of -$840.88.
- The widest annual swing landed in 2025, when Income towards Parent Company plunged 3626.53%; it then surged 126.53% in 2026.
- Tracing VYCO's Income towards Parent Company over 5 years: stood at -$678.0 in 2022, then slumped by 356.34% to -$3094.0 in 2023, then surged by 98.32% to -$52.0 in 2024, then sank by 490.38% to -$307.0 in 2025, then soared by 104.23% to $13.0 in 2026.
- Per Business Quant, the three latest VYCO Income towards Parent Company figures stand at $13.0 (Q1 2026), -$307.0 (Q4 2025), and -$54.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 |
| Dec 31, 2025 | -307.00 |
| Sep 30, 2025 | -54.00 |
| Jun 30, 2025 | -1,826.00 |
| Mar 31, 2025 | -49.00 |
| Dec 31, 2024 | -52.00 |
| Sep 30, 2024 | -47.00 |
| Jun 30, 2024 | -49.00 |
| Mar 31, 2024 | -101.00 |
| Dec 31, 2023 | -3,094.00 |
| Sep 30, 2023 | -425.00 |
| Jun 30, 2023 | -2,385.00 |
| Mar 31, 2023 | -707.00 |
| Dec 31, 2022 | -678.00 |
| Sep 30, 2022 | -2,495.00 |
| Jun 30, 2022 | -1,284.00 |
| Mar 31, 2022 | -755.00 |
| Dec 31, 2021 | -958.00 |
| Sep 30, 2021 | -3,966.00 |
| Jun 30, 2021 | -10,317.00 |
| Mar 31, 2021 | -12,172.00 |
| Dec 31, 2020 | -5,188.00 |
| Sep 30, 2020 | 22,503.00 |
| Jun 30, 2020 | -29,752.00 |
| Mar 31, 2020 | -9,735.00 |
| Dec 31, 2019 | -28,178.00 |
| Sep 30, 2019 | -26,515.00 |
| Jun 30, 2019 | -37,296.00 |
| Mar 31, 2019 | 180,298.00 |
| Dec 31, 2018 | -595,600.00 |
| Sep 30, 2018 | 152,179.00 |
| Jun 30, 2018 | 418,584.00 |
| Mar 31, 2018 | 326,636.00 |
| Dec 31, 2017 | -363,353.00 |
| Sep 30, 2017 | -428,402.00 |
| Jun 30, 2017 | -360,717.00 |
| Mar 31, 2017 | -312,791.00 |
| Dec 31, 2016 | -476,129.00 |
| Sep 30, 2016 | -331,898.00 |
| Jun 30, 2016 | -305,363.00 |
| Mar 31, 2016 | -527,564.00 |
| Dec 31, 2015 | -415,412.00 |
| Sep 30, 2015 | -506,790.00 |
| Jun 30, 2015 | -420,267.00 |
| Mar 31, 2015 | -724,180.00 |
| Sep 30, 2014 | -1.35 Mn |
| Jun 30, 2014 | -1.28 Mn |
| Mar 31, 2014 | -788,010.00 |
| Dec 31, 2013 | -623,584.00 |
| Sep 30, 2013 | -518,282.00 |
| Jun 30, 2013 | -642,423.00 |
| Mar 31, 2013 | -662,672.00 |
| Dec 31, 2012 | -542,248.00 |
| Sep 30, 2012 | -785,146.00 |
| Jun 30, 2012 | -797,734.00 |
| Mar 31, 2012 | -783,430.00 |
| Dec 31, 2011 | -858,489.00 |
| Sep 30, 2011 | -1.15 Mn |
| Jun 30, 2011 | -1.84 Mn |
| Mar 31, 2011 | -935,700.00 |
| Dec 31, 2010 | -865,027.00 |
| Sep 30, 2010 | -356,993.00 |
| Jun 30, 2010 | -420,185.00 |